Luminex Q4 Revenues Inch Up While Losses Widen | GenomeWeb

NEW YORK, Feb 1 – Luminex's fourth quarter revenues increased slightly over the quarter, while its net losses widened, the company reported Thursday.

Luminex's Q4 2000 revenues totaled $3.5 million, up from $2.3 million for the year-ago quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.